Related Experiment Video
Updated: Aug 15, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
[Lupus nephropathy in children. Based on the authors' caseload]
J Nieto Rey1, E Solé Mir, L Callis Bracons
1Hospital Infantil Vall d'Hebron, Barcelona.
Anales Espanoles De Pediatria
|November 1, 1990
Summary
Adding cyclophosphamide to oral 6-methyl-prednisolone treatment significantly improved outcomes for pediatric lupus nephritis patients, reducing mortality and enhancing renal function. This combination therapy appears beneficial for managing lupus nephritis in children.
Area of Science:
- Pediatric Nephrology
- Immunology
- Rheumatology
Background:
- Lupus nephritis is a severe complication of systemic lupus erythematosus, particularly in children.
- Optimal treatment strategies for pediatric lupus nephritis remain an area of active research.
- Early intervention is crucial to prevent long-term renal damage.
Purpose of the Study:
- To evaluate the efficacy and safety of adding cyclophosphamide to oral 6-methyl-prednisolone in treating pediatric lupus nephritis.
- To compare treatment outcomes between patients receiving 6-methyl-prednisolone alone versus those receiving 6-methyl-prednisolone plus cyclophosphamide.
Main Methods:
- Retrospective study of 12 pediatric patients with lupus nephritis.
- Patients divided into two groups: Group 1 (oral 6-methyl-prednisolone alone) and Group 2 (oral 6-methyl-prednisolone plus cyclophosphamide).
- Comparison of clinical features, renal function, laboratory values, and World Health Organization renal pathology classification at admission and during follow-up.
Main Results:
- No significant baseline differences between groups in age, sex, clinical presentation, or renal pathology.
- Group 2 (cyclophosphamide + 6-methyl-prednisolone) demonstrated significantly better outcomes.
- Improved survival rates (p<0.05), enhanced proteinuria reduction (p<0.01), and better glomerular filtration rate (p<0.05) in Group 2.
- No significant adverse effects were noted with the addition of cyclophosphamide.
Conclusions:
- Addition of cyclophosphamide to oral 6-methyl-prednisolone is a valuable therapeutic strategy for pediatric lupus nephritis.
- This combination therapy significantly improves treatment prognosis and renal function in children with lupus nephritis.
- Further prospective studies are warranted to confirm these findings and optimize treatment protocols.
Related Concept Videos
01:20Renal Corpuscle
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...